Investigating a Well-being Review in Pulmonary Hypertension
Pulmnary Hypertension
About this trial
This is an interventional treatment trial for Pulmnary Hypertension
Eligibility Criteria
Inclusion Criteria:
- in World Health Organisation (WHO) Functional Class II or III
- have a diagnosis of PH
- have started on PH drug therapy in the preceding 18 months
- showing no signs of worsening breathlessness or heart failure
- on an unchanged PH therapeutic regime for at least 6 months prior to inclusion.
Exclusion Criteria:
- have an active infection or acute exacerbation of lung disease
- have participated in a clinical study involving another investigation of drug, device or exercise within the previous 6 months
- are on a surgical or other pathway of care that has pre-determined physiotherapy or activity regimes or restrictions
- have any additional medical conditions that may adversely affect the safety of the subject or severely limit the lifespan of the subject
- have participated in rehabilitation in the last 12 months.
Sites / Locations
- Sheffield Teaching Sospitals NHS Foundation Trust
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
No Intervention
Other
Intervention
Control
Qualitative
The treatment group will have a physiotherapy well-being review and be referred for rehabilitation. They will be seen after 6 months for follow-up
The control group will have initial assessments then receive brief advice on exercise. They will also be followed up after 6 months
to understand how it feels to take part in the well-being review, we will interview some participants who have already had this kind of treatment and ask questions about their experiences of it and how it was for them. We are also interested to know what differences they felt it made so that we can help to decide about the things we want to measure as outcomes in the interventional of the study.